• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测威胁视力的糖尿病视网膜病变的诊断性循环生物标志物:未来的潜在筛查工具?

Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future?

作者信息

Frudd Karen, Sivaprasad Sobha, Raman Rajiv, Krishnakumar Subramanian, Revathy Yeddula Rebecca, Turowski Patric

机构信息

Institute of Ophthalmology, University College London, London, UK.

NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.

出版信息

Acta Ophthalmol. 2022 May;100(3):e648-e668. doi: 10.1111/aos.14954. Epub 2021 Jul 16.

DOI:10.1111/aos.14954
PMID:34269526
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086770/
Abstract

With the increasing prevalence of diabetes in developing and developed countries, the socio-economic burden of diabetic retinopathy (DR), the leading complication of diabetes, is growing. Diabetic retinopathy (DR) is currently one of the leading causes of blindness in working-age adults worldwide. Robust methodologies exist to detect and monitor DR; however, these rely on specialist imaging techniques and qualified practitioners. This makes detecting and monitoring DR expensive and time-consuming, which is particularly problematic in developing countries where many patients will be remote and have little contact with specialist medical centres. Diabetic retinopathy (DR) is largely asymptomatic until late in the pathology. Therefore, early identification and stratification of vision-threatening DR (VTDR) is highly desirable and will ameliorate the global impact of this disease. A simple, reliable and more cost-effective test would greatly assist in decreasing the burden of DR around the world. Here, we evaluate and review data on circulating protein biomarkers, which have been verified in the context of DR. We also discuss the challenges and developments necessary to translate these promising data into clinically useful assays, to detect VTDR, and their potential integration into simple point-of-care testing devices.

摘要

随着糖尿病在发展中国家和发达国家的患病率不断上升,糖尿病的主要并发症——糖尿病视网膜病变(DR)的社会经济负担也在增加。糖尿病视网膜病变(DR)目前是全球劳动年龄成年人失明的主要原因之一。现已有成熟的方法来检测和监测DR;然而,这些方法依赖于专业的成像技术和合格的从业者。这使得检测和监测DR既昂贵又耗时,在发展中国家尤其成问题,因为那里的许多患者居住在偏远地区,与专业医疗中心接触很少。糖尿病视网膜病变(DR)在病理过程后期之前大多没有症状。因此,尽早识别和分层有视力威胁的糖尿病视网膜病变(VTDR)非常必要,这将减轻这种疾病对全球的影响。一种简单、可靠且更具成本效益的检测方法将极大地有助于减轻全球范围内DR的负担。在此,我们评估并综述了已在DR背景下得到验证的循环蛋白生物标志物的数据。我们还讨论了将这些有前景的数据转化为临床有用的检测方法以检测VTDR所必需面对的挑战和进展,以及它们潜在地整合到简单的即时检测设备中的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/878a/12086770/e1529c4834d2/AOS-100-e648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/878a/12086770/e1529c4834d2/AOS-100-e648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/878a/12086770/e1529c4834d2/AOS-100-e648-g001.jpg

相似文献

1
Diagnostic circulating biomarkers to detect vision-threatening diabetic retinopathy: Potential screening tool of the future?用于检测威胁视力的糖尿病视网膜病变的诊断性循环生物标志物:未来的潜在筛查工具?
Acta Ophthalmol. 2022 May;100(3):e648-e668. doi: 10.1111/aos.14954. Epub 2021 Jul 16.
2
Current research and future strategies for the management of vision-threatening diabetic retinopathy.当前威胁视力的糖尿病视网膜病变的管理研究和未来策略。
Asia Pac J Ophthalmol (Phila). 2024 Sep-Oct;13(5):100109. doi: 10.1016/j.apjo.2024.100109. Epub 2024 Oct 10.
3
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
4
Prevalence and associated factors of diabetic retinopathy among people with diabetes screened using fundus photography at a community diabetic retinopathy screening program in Nepal.在尼泊尔的一个社区糖尿病视网膜病变筛查计划中,使用眼底摄影筛查糖尿病患者的糖尿病视网膜病变患病率及其相关因素。
BMC Ophthalmol. 2023 Oct 23;23(1):429. doi: 10.1186/s12886-023-03173-z.
5
Diabetic Retinopathy Screening at the Point of Care (DR SPOC): detecting undiagnosed and vision-threatening retinopathy by integrating portable technologies within existing services.即时护理点糖尿病视网膜病变筛查(DR SPOC):通过在现有服务中整合便携式技术,检测未确诊和威胁视力的视网膜病变。
BMJ Open Diabetes Res Care. 2023 Aug;11(4). doi: 10.1136/bmjdrc-2023-003376.
6
Agreement and Diagnostic Test Accuracy on Grading Diabetic Retinopathy Using Fundus Photographs by Allied Medical Personnel at a Community Diabetic Retinopathy Screening Program in Nepal.在尼泊尔的社区糖尿病视网膜病变筛查项目中,联合医务人员使用眼底照片对糖尿病视网膜病变进行分级的一致性和诊断测试准确性。
Ophthalmic Epidemiol. 2021 Dec;28(6):509-515. doi: 10.1080/09286586.2021.1877730. Epub 2021 Jan 27.
7
Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.西班牙卡斯蒂利亚-莱昂农村地区基于远程眼科的糖尿病视网膜病变筛查计划中患者和初级保健专业人员的满意度。
Rural Remote Health. 2020 Jan;20(1):5180. doi: 10.22605/RRH5180. Epub 2020 Jan 16.
8
Prevalence and predictors of developing vision-threatening diabetic retinopathy within the first three years of type 2 diabetes.2 型糖尿病发病后前 3 年内发生威胁视力的糖尿病视网膜病变的患病率及预测因素。
Front Endocrinol (Lausanne). 2023 Dec 20;14:1305378. doi: 10.3389/fendo.2023.1305378. eCollection 2023.
9
Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.应对糖尿病视网膜病变全球负担的策略:从流行病学到人工智能。
Ophthalmologica. 2020;243(1):9-20. doi: 10.1159/000502387. Epub 2019 Aug 13.
10
Prevalence of Diabetic Retinopathy in the US in 2021.2021 年美国糖尿病视网膜病变的患病率。
JAMA Ophthalmol. 2023 Aug 1;141(8):747-754. doi: 10.1001/jamaophthalmol.2023.2289.

引用本文的文献

1
Creatinine as a predictor of proliferative diabetic retinopathy among patients with type 2 diabetes mellitus: a systematic review and meta-analysis.肌酐作为2型糖尿病患者增殖性糖尿病视网膜病变的预测指标:一项系统评价和荟萃分析
Int Urol Nephrol. 2025 Jun 3. doi: 10.1007/s11255-025-04590-3.
2
Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis.探索白细胞分类计数比值谱作为糖尿病视网膜病变的炎症生物标志物:一项系统综述和荟萃分析
BMC Ophthalmol. 2025 May 1;25(1):265. doi: 10.1186/s12886-025-04075-y.
3
The Contributions of Glycated Hemoglobin (HbA1c), Triglycerides, and Hypertension to Diabetic Retinopathy: Insights From a Meta-Analysis.

本文引用的文献

1
Achieving a Stable High Surface Excess of Glucose Oxidase on Pristine Multiwalled Carbon Nanotubes for Glucose Quantification.在原始多壁碳纳米管上实现葡萄糖氧化酶的稳定高表面过量用于葡萄糖定量分析。
ACS Appl Bio Mater. 2019 Apr 15;2(4):1740-1750. doi: 10.1021/acsabm.9b00145. Epub 2019 Apr 3.
2
Deep learning for gradability classification of handheld, non-mydriatic retinal images.手持、非散瞳视网膜图像的可分级性分类的深度学习。
Sci Rep. 2021 May 4;11(1):9469. doi: 10.1038/s41598-021-89027-4.
3
Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes.
糖化血红蛋白(HbA1c)、甘油三酯和高血压对糖尿病视网膜病变的影响:一项荟萃分析的见解
Cureus. 2025 Feb 15;17(2):e79066. doi: 10.7759/cureus.79066. eCollection 2025 Feb.
4
Evaluating the role of serum cystatin C as a circulating biomarker of diabetic retinopathy from a rural Indian population.评估血清胱抑素C作为印度农村人群糖尿病视网膜病变循环生物标志物的作用。
Taiwan J Ophthalmol. 2024 Nov 11;14(4):573-578. doi: 10.4103/tjo.TJO-D-24-00096. eCollection 2024 Oct-Dec.
5
The association between fibroblast growth factor 21 with diabetes retinopathy among type 2 diabetes mellitus patients: a systematic review, meta-analysis, and meta-regression.2型糖尿病患者中,成纤维细胞生长因子21与糖尿病视网膜病变的关联:一项系统评价、荟萃分析和荟萃回归分析
PeerJ. 2024 Dec 13;12:e18308. doi: 10.7717/peerj.18308. eCollection 2024.
6
Exploring the Association of VEGF-A and ANGPTL2 with the Prognosis of Non-proliferative and Proliferative Diabetic Retinopathy.探索血管内皮生长因子-A(VEGF-A)和血管生成素样蛋白2(ANGPTL2)与非增殖性和增殖性糖尿病视网膜病变预后的相关性。
Cureus. 2024 Aug 31;16(8):e68273. doi: 10.7759/cureus.68273. eCollection 2024 Aug.
7
Gut microbiota and eye diseases: A review.肠道微生物群与眼部疾病:综述
Medicine (Baltimore). 2024 Sep 27;103(39):e39866. doi: 10.1097/MD.0000000000039866.
8
The disruptive role of LRG1 on the vasculature and perivascular microenvironment.LRG1对脉管系统和血管周围微环境的破坏作用。
Front Cardiovasc Med. 2024 Apr 30;11:1386177. doi: 10.3389/fcvm.2024.1386177. eCollection 2024.
9
A Narrative Review of the Advances in Screening Methods for Diabetic Retinopathy: Enhancing Early Detection and Vision Preservation.糖尿病视网膜病变筛查方法进展的叙述性综述:加强早期检测与视力保护
Cureus. 2024 Feb 4;16(2):e53586. doi: 10.7759/cureus.53586. eCollection 2024 Feb.
10
Navigating the Frontier: Emerging Techniques for Detecting Microvascular Complications in Type 2 Diabetes Mellitus: A Comprehensive Review.探索前沿:2型糖尿病微血管并发症检测的新兴技术:全面综述
Cureus. 2024 Jan 31;16(1):e53279. doi: 10.7759/cureus.53279. eCollection 2024 Jan.
长期糖化血红蛋白变异性与 2 型糖尿病患者糖尿病视网膜病变的发生和进展。
Sci Rep. 2021 Feb 26;11(1):4731. doi: 10.1038/s41598-021-84150-8.
4
Recent trends in smartphone-based detection for biomedical applications: a review.基于智能手机的生物医学应用检测的最新趋势:综述。
Anal Bioanal Chem. 2021 Apr;413(9):2389-2406. doi: 10.1007/s00216-021-03184-z. Epub 2021 Feb 15.
5
Current understanding of the molecular and cellular pathology of diabetic retinopathy.糖尿病视网膜病变的分子和细胞病理学的现有认识。
Nat Rev Endocrinol. 2021 Apr;17(4):195-206. doi: 10.1038/s41574-020-00451-4. Epub 2021 Jan 19.
6
Diabetic Retinopathy Environment-Wide Association Study (EWAS) in NHANES 2005-2008.2005 - 2008年美国国家健康与营养检查调查(NHANES)中的糖尿病视网膜病变全环境关联研究(EWAS)
J Clin Med. 2020 Nov 12;9(11):3643. doi: 10.3390/jcm9113643.
7
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.个体化糖尿病视网膜病变筛查的安全性和成本效益:ISDR 开放性标签、等效 RCT。
Diabetologia. 2021 Jan;64(1):56-69. doi: 10.1007/s00125-020-05313-2. Epub 2020 Nov 4.
8
Microfluidic electrochemical immunosensor for the determination of cystatin C in human serum.微流控电化学免疫传感器用于测定人血清中的胱抑素 C。
Mikrochim Acta. 2020 Sep 30;187(10):585. doi: 10.1007/s00604-020-04503-4.
9
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden.糖尿病并发症的成本:瑞典 392200 例 2 型糖尿病患者和匹配对照参与者的基于医院的护理和旷工成本。
Diabetologia. 2020 Dec;63(12):2582-2594. doi: 10.1007/s00125-020-05277-3. Epub 2020 Sep 24.
10
Comparison of smartphone-based retinal imaging systems for diabetic retinopathy detection using deep learning.基于深度学习的用于糖尿病视网膜病变检测的智能手机视网膜成像系统比较。
BMC Bioinformatics. 2020 Jul 6;21(Suppl 4):259. doi: 10.1186/s12859-020-03587-2.